GWPH | GW Pharmaceuticals Plc
131.85 -3.11 (-2.3%)
GW has established a world leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise.
About the Company
GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols. Sativex is the first natural cannabis plant derivative to gain market approval in any country.
Key Persons / Board of Directors
Videos about GW Pharmaceuticals Plc
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!